tiprankstipranks
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF

MediPharm Labs (MEDIF) Technical Analysis

405 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
MediPharm Labs’s (MEDIF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting MediPharm Labs is a Sell.
MediPharm Labs’s (MEDIF) 20-Day exponential moving average is 0.06, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.
MediPharm Labs’s (MEDIF) 50-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.

MediPharm Labs (MEDIF) Pivot Points

May 02, 2024, 01:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.07
0.07
0.07
0.07
0.07
Fibonacci
0.06
0.06
0.07
0.07
0.07
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MediPharm Labs (MEDIF) Moving Averages

May 02, 2024, 01:49 AM
Period
Simple
Exponential
MA5
0.06Sell
0.06Sell
MA10
0.06Sell
0.06Sell
MA20
0.06Buy
0.06Buy
MA50
0.05Buy
0.05Buy
MA100
0.05Buy
0.05Buy
MA200
0.05Buy
0.05Buy
MediPharm Labs’s (MEDIF) 10-Day exponential moving average is 0.06, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Sell.
MediPharm Labs’s (MEDIF) 100-Day exponential moving average is 0.05, while MediPharm Labs’s (MEDIF) share price is <$0.1, making it a Buy.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 50-day simple moving average is 0.05, creating a Buy signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 100-day simple moving average is 0.05, creating a Buy signal.
MediPharm Labs’s (MEDIF) stock price is <$0.1 and MediPharm Labs’s (MEDIF) 200-day simple moving average is 0.05, creating a Buy signal.

MediPharm Labs (MEDIF) Technical Indicators

May 02, 2024, 01:49 AM
Name
Value
Implied Action
RSI (14)
55.00
Neutral
STOCH (9,6)
53.91
Neutral
STOCHRSI (14)
65.58
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
31.41
Neutral
Williams %R
-48.28
Buy
CCI (14)
66.33
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
38.73
Neutral
ROC
20.00
Buy
MediPharm Labs’s (MEDIF) Relative Strength Index (RSI) is 55.00, creating a Neutral signal.
MediPharm Labs’s (MEDIF) Trend Strength Indicator (ADX) is 31.41, creating a Neutral signal.
MediPharm Labs’s (MEDIF) Commodity Channel Index (CCI) is 66.33, creating a Neutral signal.
MediPharm Labs’s (MEDIF) Price Rate of Change (ROC) is 20.00, creating a Buy signal.

FAQ

Is MEDIF a Buy, Hold, or Sell?
Based on MEDIF’s technical indicators, MEDIF is a Buy.
    What is MEDIF’s RSI (14)?
    MEDIF’s RSI (14) is 55.00, which suggests MEDIF is a Neutral.
      What is MEDIF’s MACD?
      MEDIF’s MACD is <0.01, which suggests MEDIF is a Sell.
        What is MEDIF’s 5-day moving average?
        MEDIF’s 5-day moving average is 0.06, which suggests MEDIF is a Sell.
          What is MEDIF’s 20-day moving average?
          MEDIF 20-day moving average is 0.06, which suggests MEDIF is a Buy.
            What is MEDIF’s 50-day moving average?
            MEDIF’s 50-day moving average is 0.05, which suggests MEDIF is a Buy.
              What is MEDIF’s 200-day moving average?
              MEDIF’s 200-day moving average is 0.05, which suggests MEDIF is a Buy.
                What is MEDIF’s Williams % R (14)?
                MEDIF’s Williams % R (14) is -48.28, which suggests MEDIF is a Buy.
                  What is MEDIF’s CCI (14)?
                  MEDIF’s CCI (14) is 66.33, which suggests MEDIF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis